San Francisco State University (SFSU), the University of California, Davis (UCD) and the University of California, San Francisco (UCSF) called PhD Partners hereafter, have developed a cooperative graduate program to increase the number of underrepresented minorities (URM) that pursue biomedical research careers. Our program goals are to provide URM students with a quality and focused master's degree education at SFSU that prepares them to be competitive for acceptance and successful in top-ranked biomedical science doctoral programs. The objectives are to ensure that the master's degree Bridge students: 1) pursue a critical and exhaustive examination of discipline subject matter graduate courses that lead to an MA/MS degree in a biomedical science (i.e. biology, biochemistry or chemistry) in two-three years; 2) achieve competitive scores on their GRE exams to ensure acceptance into a high quality biomedical PhD programs; 3) receive intense advising and the support necessary to become confident and successful graduate students; 4) participate in significant research experiences and acquire the skills required to communicate the results of those experiences in the form of theses, presentations at national scientific conferences and in peer-reviewed journals; 5) develop strong skills in science writing, and 6) receive continual exposure to successful minority scientists to build the confidence they will need to become outstanding scientists. These objectives will be successfully met through the combination of an excellent curriculum, close and careful advising, workshops designed to provide the students with a well-rounded and in-depth knowledge of all aspects of biomedical sciences, and a nurturing and productive research experience with Bridge mentors. These activities will prepare URM students for entry into high quality PhD degree programs, and/or biomedical research careers. Sixty-four of our past MS/PhD Bridge to the Doctorate masters' students are currently enrolled in or have completed Doctoral programs at UC Partner campuses or other outstanding doctoral institutions. Nine other MS/PhD Bridge students who entered PhD programs withdrew for various reasons. Therefore, 87.7% (64/73) of SFSU Bridge students have persisted in pursuit of a PhD degree. Forty-three have completed doctoral programs to date (34 PhD, 4 PharmD, 4 MD/DO and 1 DVM). Six of the current MS candidates in the Bridge program will apply in 2014 for admission into PhD programs for fall 2015 and another three that have completed the MS degree will re-apply this fall. Thus, 114 graduate students have received Bridge program financial support since 1992. Eighty-five have entered doctoral programs or are currently supported on the Bridge grant (six second-year Bridge participants applied to PhD programs in fall 2013 and six second-year Bridge students will apply in Fall 2014 for entrance in Fall 2015). Thus, 79.3% (85+3/111) of all past and current SFSU Bridge participants are in positions to complete/enter doctoral degree programs. The remaining 23 students have gone into industry, RA positions at UCSF, UC Berkeley and Stanford U or teaching.

Public Health Relevance

The SFSU/UC MS/PhD Bridge Collaborative Doctoral Program prepares master's graduates who continue into biomedical PhD degree programs in route to careers as research scientists. The partnership between the Minority Serving Master's I institution and two pre- eminent PhD granting institutions addresses workforce needs to prepare researchers to address health disparity issues.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Education Projects (R25)
Project #
Application #
Study Section
Special Emphasis Panel (TWD)
Program Officer
Hamlet, Michelle R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
San Francisco State University
Schools of Arts and Sciences
San Francisco
United States
Zip Code
Erden, Ihsan; Gärtner, Christian; Ma, Jingxiang et al. (2017) Cyclopentadienones via a tandem C-cyclopropylnitrone cyclization-cycloreversion sequence. European J Org Chem 2017:5147-5153
Sharma, Bikram; Ho, Lena; Ford, Gretchen Hazel et al. (2017) Alternative Progenitor Cells Compensate to Rebuild the Coronary Vasculature in Elabela- and Apj-Deficient Hearts. Dev Cell 42:655-666.e3
Erden, Ihsan; Gronert, Scott; Cabrera, Gabriel et al. (2017) Diverse modes of reactivity of 6-(chloromethyl)-6-methylfulvene. European J Org Chem 2017:2925-2931
McGraw, Kristen M; Kent, Greggory T; Gonzalez, Joseph R et al. (2017) Competitive, substrate-dependent reductive debromination/dehydrobromination of 1,2-dibromides with triethylamine. Tetrahedron Lett 58:1973-1975
Erden, Ihsan; Basada, John; Poli, Daniela et al. (2016) Unusual hydroxyl effect on fulvene endoperoxide decompositions. Tetrahedron Lett 57:2190-2193
McMackin, Marissa Zubia; Lewin, Matthew R; Tabuena, Dennis R et al. (2016) Use of von Frey filaments to assess nociceptive sensitization in the hornworm, Manduca sexta. J Neurosci Methods 257:139-46
Mostafavi, Mina; Lewis, Jainee Christa; Saini, Tanisha et al. (2014) Analysis of a taurine-dependent promoter in Sinorhizobium meliloti that offers tight modulation of gene expression. BMC Microbiol 14:295
Lauron, Elvin J; Oakgrove, Khouanchy S; Tell, Lisa A et al. (2014) Transcriptome sequencing and analysis of Plasmodium gallinaceum reveals polymorphisms and selection on the apical membrane antigen-1. Malar J 13:382
Martinez, Criseyda; Marzec, Timothy; Smith, Christopher D et al. (2013) Identification and expression of maebl, an erythrocyte-binding gene, in Plasmodium gallinaceum. Parasitol Res 112:945-54
Fields, Alexander T; Navarrete, Charlene S; Zare, Alaa Ziad et al. (2012) The conserved polarity factor podJ1 impacts multiple cell envelope-associated functions in Sinorhizobium meliloti. Mol Microbiol 84:892-920

Showing the most recent 10 out of 18 publications